What is MetroLaser?
MetroLaser operates at the intersection of advanced photonics and structural integrity, providing state-of-the-art optical diagnostic solutions. The company's portfolio is anchored by digital holographic microscopes and non-destructive evaluation systems, which are essential for the rigorous quality control requirements of the aerospace and defense sectors. By focusing on additively manufactured parts, MetroLaser addresses a critical bottleneck in modern industrial production, ensuring that complex components meet stringent safety and performance standards.
The firm's historical trajectory is marked by a series of technical breakthroughs and industry accolades, including recognition as a National Small Business Prime Contractor of the Year. With a robust patent portfolio, MetroLaser maintains a competitive edge in the development of laser-based instrumentation, effectively bridging the gap between laboratory-grade innovation and field-ready industrial applications.
How much funding has MetroLaser raised?
MetroLaser has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MetroLaser
PPP
Public-Private Partnership
What's next for MetroLaser?
With the successful acquisition of this latest financing, MetroLaser is poised to transition into a phase of aggressive commercial expansion. The strategic roadmap likely involves scaling the production of its non-destructive evaluation systems to meet the growing demand for quality assurance in additive manufacturing. Furthermore, the company is expected to deepen its engagement with defense and aerospace partners, leveraging its expertise to solve increasingly complex structural mechanics challenges.
As the industry shifts toward more automated and precise manufacturing processes, MetroLaser's role as a technical authority in optical diagnostics becomes increasingly vital. The current capital structure provides the necessary runway to refine existing product lines and explore new market verticals, ensuring that the company remains at the forefront of the photonics revolution while maintaining its reputation for high-fidelity diagnostic excellence.
